Hospital Tijuana is one of a network of 22 Angeles Health hospitals across Mexico. We are proud to be at the forefront of many ground-breaking procedures and our specialists are respected throughout their fields of expertize, offering training and advice, training and seminars to US-based medical Universities and facilities. Hospital Tijuana is known as a BioHeart Stem Cell Center of Excellence and the treatment that we offer is the best in its field. We offer cardiovascular disease patients innovative therapies with the exceptional levels of quality and confidence that a Center of Excellence guarantees.

What is BioHeart?
Florida-based biotechnology company, Bioheart is a leading regenerative medicine company engaged in the discovery, development and commercialization of autologous adult stem cell (A-ASC) therapies and devices to treat cardiovascular disease. Established in 1999, BioHeart focuses solely on the treatment of cardiovascular related diseases, conducting research and using different cell types to help heal damage to the heart, the only organ in the body that is thought to be unable to repair itself.

What is a Center of excellence?
A Center of excellence (CoE) consists of a group of experienced professionals and researchers who work together to establish and promote best practice through shared learning, establishing treatment protocols and measuring results. CoEs work well to ensure that patients receive the best possible level of treatment by using the multi-disciplinary input of medical professionals who each adhere to their formally appointed body of expertize, ensuring the highest levels of quality in investigative research and treatment.

Hospital Angeles Tijuana, Mexico
The Regenerative Medicine Institute of Tijuana Mexico consists of a group of Board Certified physicians and allied health professionals from a range of specialties working together to provide cutting edge therapies to patients living with congestive heart failure (CHF), experiencing chronic ischemia (CI) and chronic limb ischemia (CLI). The range of professionals working in partnership with BioHeart offers a wide range of knowledge, enabling us to provide ever-improving treatments for heart conditions.

The Academic Advisory Committee
Doctors of Columbia University Medical Center’s Stem Cell Research Institute and Duke University’s Clinical Research Institute have established an Academic Advisory Committee with Bioheart. Through this committee and in partnership with Hospital Angeles Tijuana’s Center of Excellence, they are working to monitor the progress and gather data on CHF patients.

The partnership of the Center of Excellence, Bioheart and the Academic Advisory Committee means that Stem Cell Therapy Mexico at Angeles Health is at the cutting edge of Stem Cell treatment for CHF. Together we feed information gathered back to the medical community, helping the advancement of the use of Adult Stem Cells for heart disease whilst offering our patients the very best treatment available.

If you would like to know more about Stem Cell Mexico visit our website www.stemcellmex.com